Immunizations in immunocompromised cancer patients

Infections in Medicine

Volumn 13, Issue 4, 1996, Pages 259-280

  Molrine, Deborah C ^a,b   Ambrosino, Donna M ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

bone marrow transplantation; cancer; Hodgkin's disease; immunization

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; INFLUENZA VACCINE; MEASLES VACCINE; MENINGOCOCCUS VACCINE; MUMPS VACCINE; PNEUMOCOCCUS VACCINE; RUBELLA VACCINE;

BONE MARROW TRANSPLANTATION; CANCER; CANCER CHEMOTHERAPY; HODGKIN DISEASE; HUMAN; IMMUNE DEFICIENCY; IMMUNIZATION; REVIEW;

EID: 0029922530     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Siber GR: Bacteremias due to Haemophilus influenzae and Streptococcus pneumoniae. Am J Dis Child 34:668-672, 1980.
2. Feldman S, Gigliotti F, Shenep JL, et al: Risk of Haemophilia influenzae type b disease in children with cancer and response of immunocompromised leukemic children to a conjugate vaccine. J Infect Dis 161:926-931, 1990.
3. Ridgway P, Wolff LJ, Deforest A: Immunization response varies with intensity of acute lymphoblastic leukemia therapy. Am J Dis Child 145:887-891, 1991.
4. Butler JC, Breiman RF, Campbell JF, et al: Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA 270:1826-1831, 1993.
5. Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of vaccines and immune globulins in persons with altered immunocompetence. MMWR 42 (RR-4):1-3, 7-9, 15-16, 1993.
6. Kung FH, Orgel HA, Wallace WW, et al: Antibody production following immunization with diphtheria and tetanus-toxoids in children receiving chemotherapy during remission of malignant disease. Pediatrics 74:86-89, 1984.
7. Ambrosino DM, Molrine DC: Critical appraisal of immunization strategies for prevention of infection in the compromised host. Hematol Oncol Clin North Am 7:1027-1050, 1993.
8. Committee on Infectious Diseases. Recommendations for the use of live attenuated varicella vaccine. Pediatrics 95:791-796, 1995.
9. Gershon AA, Steinberg SP, and the Varicella Vaccine Collaborative Study Group of the National Institute of Allergy and Infectious Diseases: Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine. N Engl J Med 320:892-897, 1989.
10. Chilcote RR, Baehner RL, Hammond D, et al: Septicemia and meningitis in children splenectomized for Hodgkin's disease. N Engl J Med 295:798-800, 1976.
11. Notter DT, Grossman PL, Rosenberg SA, et al: Infections in patients with Hodgkin's disease: A clinical study of 300 consecutive adult patients. Rev Infect Dis 2:761-800, 1980.
12. Weitzman S, Aisenberg AC: Fulminant sepsis after successful treatment of Hodgkin's disease. Am J Med 62:47-50, 1977.
13. Weitzman SA, Aisenberg AC, Siber GR, et al: Impaired humoral immunity in treated Hodgkin's disease. N Engl J Med 297:245-248, 1977.
14. Siber GR, Weitzman SA, Aisenberg AC, et al: Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease. N Engl J Med 299:442-448, 1978.
15. Siber GR, Weitzman SA, Aisenberg AC: Antibody response of patients with Hodgkin's disease to protein and polysaccharide antigens. Rev Infect Dis 3(S):S144-S159, 1981.
16. Donaldson SS, Vosti KL, Berberich FR, et al: Response to pneumococcal vaccine among children with Hodgkin's disease. Rev Infect Dis 3(S):S133-S143, 1981.
17. Molrine DC, George S, Tarbell N, et al: Antibody responses to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin's Disease. Ann Intern Med 123:828-834, 1995.
18. Chan CY, Molrine DC, George S, et al: Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's Disease. J Infect Dis 173:256-258, 1996.
19. Lum LG: The kinetics of immune reconstitution after human marrow transplantation. Blood 69:368-380, 1987.
20. Meyers JD: Infection in bone marrow transplant recipients. Am J Med 81 (suppl 1A):S27-S38, 1986.
21. Noel DR, Witherspoon RP, Storb R, et al: Does graft-versus-host disease influence the tempo of immunologie recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors. Blood 51:1087-1105, 1978.
22. Aucouturier P, Barra A, Intrator L, et al: Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. Blood 70:779-785, 1987.
23. Atkinson K, Storb R, Prentice RI, et al: Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 53:360-368, 1979.
24. Winston DJ, Schiffman G, Wang DC, et al: Pneumococcal infections after human bone marrow transplantation. Ann Intern Med 91:835-841, 1979.
25. Hoyle C, Goldman JM: On behalf of 18 UK bone marrow transplant teams: Life-threatening infections occurring more than 3 months after BMT. Bone Marrow Transplant 14:247-252, 1994.
26. Cordonnier C, Bernaudin J-F, Bierling P, et al: Pulmonary complications occurring after allogeneic bone marrow transplantation. Cancer 58:1047-1054, 1986.
27. Winston DJ, Winston GH, Schiffman G, et al: Pneumococcal vaccination of recipients of bone marrow transplants. Arch Intern Med 143:1735-1737, 1983.
28. Giebink GS, Warkentin PI, Ramsay NKC, et al: Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine. J Infect Dis 154:590-596, 1986.
29. Barra A, Cordonnier C, Preziosi MP, et al: Immunogenicity of Haemophilus influenzas type b conjugate vaccine in allogeneic bone marrow recipients. J Infect Dis 166:1021-1028, 1992.
30. Guinan EC, Molrine DC, Antin JH, et al: Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation 57:677-684, 1994.
31. Pauksen K, Hammerström V, Ljungman P, et al: Immunity to poliovirus and immunization with inactivated poliovirus vaccine after autologous bone marrow transplantation. Clin Infect Dis 18:547-552, 1994.
32. Pauksen K, Daraj V, Ljungman P, et al: Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation. Bone Marrow Transplant 9:427-432, 1992.
33. Ljungman P, Wiklund-Hammarsten M, Duraj V, et al: Responses to tetanus-toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis 162:496-500, 1990.
34. Ljungman P, Fridell E, Lonnqvist B, et al: Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis 159:610-615, 1989.
35. Molrine DC, Guinan EC, Antin JH, et al: Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation. Blood. In press.
36. Molrine DC, Guinan EC, Antin JH, et al: Haemophilus influenzae type b (HIB)-conjugate immunization before bone marrow harvest in autologous bone marrow transplantation. Bone Marrow Transplant. In press.
37. Breiman RF, Butler JC, Tenover FC, et al: Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271:1831-1835, 1994.
38. Plotkin SA: Vaccines for varicella-zoster virus and cytomegalovirus: Recent progress. Science 265:1383-1385, 1994.
39. Mannheimer S, Armstrong D: Vaccination for the immunocompromised traveler. Infections in Medicine 12:415-419, 1995.
40. Ilan Y, Nagler A, Adler R, et al: Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation. Hepatology 18:246-252, 1993.
41. Gardner P, Eickhoff T, Poland GA, et al. Adult Immunizations. Ann Intern Med 124:35-40, 1996.
42. Nagler A, Ilan Y, Adler R, et al. Successful immunization of autologous bone marrow transplantation recipients against hepatitis B virus by active vaccination. Bone Marrow Transplant 15:475-478, 1995.
43. Hovi L, Valle M, Siimes MA, et al: Impaired response to hepatitis B vaccine in children receiving anticancer chemotherapy. Pediatr Infect Dis J 14:931-935, 1995.